Back
Heron Therapeutics Stock Price Chart
Sponsored
HRTX
Sponsored
Free Stock Analysis: See What Your Stock is Really Worth
Analyze Any Stock Free
Sell
31
HRTX
Heron Therapeutics
Last Price:
$1.55
Seasonality Move:
1.16%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock Free-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRTX is experiencing slight selling pressure.
Heron Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.62 | Sell |
20-day SMA: | 1.61 | Sell |
50-day SMA: | 1.52 | Buy |
200-day SMA: | 2.35 | Sell |
8-day EMA: | 1.62 | Sell |
20-day EMA: | 1.59 | Sell |
50-day EMA: | 1.61 | Sell |
200-day EMA: | 2.02 | Sell |
Heron Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 48.19 | Sell |
Chaikin Money Flow: | -274773 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.56 - 1.7) | Sell |
Bollinger Bands (100): | (1.44 - 1.98) | Sell |
Heron Therapeutics Technical Analysis
Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Heron Therapeutics Stock
Is Heron Therapeutics Stock a Buy?
-
Heron Therapeutics share price is 1.55 while HRTX 8-day simple moving average is 1.62, which is a Sell signal.
-
The stock price of HRTX is 1.55 while Heron Therapeutics 20-day SMA is 1.61, which makes it a Sell.
-
Heron Therapeutics 50-day simple moving average is 1.52 while HRTX share price is 1.55, making it a Buy technically.
-
HRTX stock price is 1.55 and Heron Therapeutics 200-day simple moving average is 2.35, creating a Sell signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
31
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy or a Sell?
-
Heron Therapeutics stock is rated a SellThe current Heron Therapeutics [HRTX] share price is $1.55. The Score for HRTX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics Stock Info
Market Cap:
235.7M
Price in USD:
1.55
Share Volume:
1.1M
Heron Therapeutics 52-Week Range
52-Week High:
3.93
52-Week Low:
1.04
Sell
31
Heron Therapeutics (HRTX)
is a Sell
Heron Therapeutics Share Price Forecast
-
What is the Heron Therapeutics stock price today?The Heron Therapeutics stock price is 1.55 USD today.
-
Will HRTX stock go up or go down?Heron Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Heron Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics is overvalued.
Is Heron Therapeutics Stock a Buy?
-
Heron Therapeutics share price is 1.55 while HRTX 8-day exponential moving average is 1.62, which is a Sell signal.
-
The stock price of HRTX is 1.55 while Heron Therapeutics 20-day EMA is 1.59, which makes it a Sell.
-
Heron Therapeutics 50-day exponential moving average is 1.61 while HRTX share price is 1.55, making it a Sell technically.
-
HRTX stock price is 1.55 and Heron Therapeutics 200-day simple moving average is 2.02, creating a Sell signal.
Fundamental Analysis of Heron Therapeutics
Is Heron Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.20 per share.
Technical Analysis of Heron Therapeutics
Should I short Heron Therapeutics stock?
-
HRTX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Heron Therapeutics is a Buy
-
Heron Therapeutics Relative Strength Index (RSI) is 48.19, which suggest Heron Therapeutics is oversold
-
The Bollinger Bands (25) for Heron Therapeutics is (1.56 - 1.7), which suggest Heron Therapeutics is a Sell
-
The Bollinger Bands (100) for Heron Therapeutics is (1.44 - 1.98), which suggest Heron Therapeutics is a Sell
* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.